Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature

Mol Genet Metab Rep. 2021 Jan 29:26:100714. doi: 10.1016/j.ymgmr.2021.100714. eCollection 2021 Mar.

Abstract

Mucopolysaccharidosis are genetic disorders due to deficiency of lysosomal enzymes, resulting in abnormal glycosaminoglycans accumulation in several tissues. Heart involvement tends to be progressive and worsens with age. We describe the first case of mucopolysaccharidosis type I presenting with noncompaction/dilated-mixed cardiomyopathy and heart failure within neonatal period, which responded successfully to specific metabolic treatment. Cardiac function recovered after enzyme replacement therapy and hematopoietic stem cell transplantation, adding to the existing knowledge of the disease.

Keywords: Cardiac failure; Cardiomyopathy; ERT, Enzyme Replacement Therapy; GAGs, Glycosaminoglycans; HSCT, Hematopoietic Stem Cell Transplantation; Heart failure; LV, Left Ventricular; LVEV, Left Ventricular Ejection Fraction; MPS, Mucopolysaccharidosis; Mucopolysaccharidosis; Neonatal; Noncompaction.

Publication types

  • Case Reports